Clinical reports have demonstrated that function-loss mutations in the SLC12A3 gene, particularly including p.D486N, p.T60M, c.506-1G>A, p.S710X, c.2548 + 253C>T, and p.C430G, contribute to the pathogenic effects observed in GS. The gene discussed is SLC12A3; the disease is Gerstmann syndrome.